We are excited to announce that Dr. Onisiforou from our lab is currently participating in IDWeek 2024, taking place in Los Angeles, USA. IDWeek is a premier international conference bringing together researchers and clinicians to discuss the latest advancements in infectious diseases.
At the conference, Dr. Onisiforou is presenting her novel research on the molecular mechanisms linking infections to neuropsychiatric symptoms in Alzheimer’s disease. Her poster, titled “Dissecting the Contribution of Herpesviruses in the Emergence of Depressive Symptoms in Alzheimer’s Disease through Multi-Omics Data,” highlights groundbreaking findings on how herpesviruses may play a role in the onset of depressive symptoms in Alzheimer’s patients, utilizing cutting-edge multi-omics data analysis.
We are proud of Dr. Onisiforou’s continued contributions to this important area of research and her commitment to advancing our understanding of the complex relationship between infections and neurodegenerative diseases.
For more information on the conference, visit the IDWeek website.